Langenberg Starts Cellectar Biosciences (CLRB) at Buy, $2.70 PT
Tweet Send to a Friend
Ladenburg Thalmann analyst Wangzhi Li launches coverage on Cellectar Biosciences (NASDAQ: CLRB) with a Buy rating $2.70 price target telling ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
